VQS-10430-62411
3 vaccinations
2 coded responses
18 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 981 / WA
- Registered
- 2021-01-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-17
Dose 1 — Pfizer-BioNTech
-
2021-01-01
Dose 2 — Pfizer-BioNTech
-
2021-01-07
Registered in v-safe
- 2021-01-08
- 2021-01-15
- 2021-01-22
- 2021-07-02
-
2021-09-28
Dose 3 — Pfizer-BioNTech
- 2021-09-28
-
2021-09-29
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-09-30
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-10-02
- 2021-10-03
- 2021-10-04
- 2021-10-05
- 2021-10-12
- 2021-10-19
- 2021-10-26
- 2021-11-02
- 2021-11-09
-
2021-12-28
Survey response — 3 months, dose 3MedDRA: Hypertension — Feeling: Fair · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Slight HypertensionMedDRA releases: 2024-11 · check-in free text available
-
2021-12-28
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
- 2021-12-29
-
2022-03-29
Survey response — 6 months, dose 3MedDRA: Anaemia — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: AnemiaMedDRA releases: 2024-11 · check-in free text available
-
2022-03-29
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-03-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-17 | Pfizer-BioNTech | |
| 2 | 2021-01-01 | Pfizer-BioNTech | |
| 3 | 2021-09-28 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-12-28 | Unsuccessful | |
| 2022-03-29 | Unsuccessful |
Free text
Release 10 — 3 months, dose 3
Symptoms: Slight Hypertension
Release 11 — 6 months, dose 3
Symptoms: Anemia
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anaemia | · | · | ✓ |
| SD | Hypertension | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release